Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

There is no public data for Rexista.

Rexista is a hardshell ADF that gums up when hydrated to resist injection. IPCI says it is "difficult" to vaporize or inhale from burning. The technology could be applied to other agonists, but each will require reformulation.

IPCI has not to my knowledge ever disclosed any kind data, including HAL results. There are no pharmokinetic or drug liking curves available to compare, so nobody has any factual basis to say Rexista is any better or worse than any other hardshell ADF that gums up. One thing that confuses a lot of people is the overdose protection system known as PODRAS. It is purely conceptual, but the way IPCI has presented it tends to make some investors believe it is ready to file NDA now. PODRAS is years away from anything. Rexista with nPODDDs is the hardshell version supposedly ready to file NDA without Phase 3, so we'll get a look at the data soon enough.

One thing for sure Rexista does that Elite's platform does not:

http://files.shareholder.com/downloads/ABEA-43EQSZ/180376177x0x881307/0AA81A60-E645-4481-8DED-AD17516D579E/Roth_Investor_Conference_March_2016_upload_version.pdf

Abuse by grinding, chewing, licking, inhalation, snorting, and
insufflation releases a stigmatizing blue dye.

ELTP antagonist ADF would precipitate acute opioid withdrawal if abused by grinding, chewing, licking, inhalation, snorting, or
insufflation- including terrible nausea and wretching and whole body pain. But no stigmatizing blue dye, sorry.